GCSAA wanted to provide a few quick updates on legal activity regarding glyphosate, which occurred during the month of June:
- Glyphosate litigation court case in St. Louis. Bayer AG notched a third consecutive court victory in the U.S. on June 10, 2022, over its Roundup weedkiller after a jury in Missouri rejected a claim that it causes cancer, days before the eagerly anticipated Supreme Court announcement on the Hardeman case from San Francisco.
- Movement on lawsuit over glyphosate interim registration decision. In January 2020, as part of the ongoing routine registration review of glyphosate in the U.S., the EPA published its interim registration decision (ID) on glyphosate. In March 2020, a group of NGOs filed petitions with the U.S. Court of Appeals for the Ninth Circuit challenging the EPA’s ID on glyphosate. GCSAA is intervenor in the case. In January 2022, the Court heard arguments in the case. On June 17, 2022, the Court issued its ruling. The Court granted in part and denied in part the NGOs’ petition. Most notably, the Court vacated the human health portion of the EPA’s interim decision and remanded it back to the EPA for “further analysis and explanation.” Current glyphosate product registrations remain in place, and growers and other users can continue to use the products based on the current label instructions.
- U.S. Supreme Court denies review of Bayer’s Hardeman appeal. On June 21, 2022, the Supreme Court declined to hear Bayer’s appeal on the Roundup case generating out of San Francisco. The judges said they would not hear the case, leaving in place a ruling upholding a $25 million award to a Roundup user in California, who had claimed that his use of the glyphosate-based product on his property led to his cancer. Read Bayer’s comprehensive statement here. Details about the company’s next steps are included in the statement. The Pilliod case appeal is also being considered by SCOTUS.
For further questions, please contact Chava McKeel, director, government affairs, at (800) 472-7878.